• FirefoxInstall the new Firefox »
  •  Dow Down 0.47% Nasdaq Down 0.56%

    ImmunoGen, Inc. (IMGN)

    -NasdaqGS
    7.54 Down 0.35(4.44%) Mar 3, 4:00PM EST
    Add to Portfolio
    Prev Close:7.89
    Open:7.89
    Bid:5.82 x 200
    Ask:N/A
    1y Target Est:8.02
    Beta:1.27
    Earnings Date:Apr 23 - Apr 27 (Est.)
    Day's Range:7.43 - 7.90
    52wk Range:5.34 - 17.23
    Volume:1,091,935
    Avg Vol (3m):1,860,170
    Market Cap:649.25M
    P/E (ttm):N/A
    EPS (ttm):-0.85
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    IMGNDown 4.44%649.25M
    PFEDown 0.60%211.81B
    RHHBYUp 1.07%N/A
    SGENDown 2.36%4.37B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):9.17
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-15) :-0.65
    Quarterly EPS Est (Mar-15) :-0.25
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ImmunoGen, Inc., a biotechnology company, develops targeted anticancer therapeutics. It develops its products using its antibody-drug conjugates technology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback